ÂÜÀòÂÒÂ×

Dr. Philip M. Brown has over 25 years of experience leading clinical development programs. Prior to joining Dermavant in January 2019, Dr. Brown served as head of global pharmaceutical development at Galderma. He also served in other clinical development leadership roles in both public and private biotechnology companies, including Senior Vice President of Clinical Development at Lexicon Pharmaceuticals, a publicly traded biopharmaceutical company. Dr. Brown received his MD from Texas Tech University Health Science Center School of Medicine, his JD from the University of Texas School of Law and his BA from Hendrix College.